Furbenicillin is a semisynthetic penicillin with high activity against Pseudomonas aeruginosa, exhibiting strong binding affinity to multiple essential penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa. It shows high affinity for PBP2 and PBP3 of E. coli, as well as strong affinity for PBP1α and PBP1b. Against P. aeruginosa, its affinity for PBP1α, PBP2, and PBP3 surpasses that of piperacillin, and its binding to PBP2 and PBP3 is significantly stronger than that of cefoperazone. Furbenicillin also demonstrates excellent outer membrane permeability, making it the most valuable acylureido penicillin for treating P. aeruginosa infections. It is primarily indicated for infections caused by Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, and other susceptible bacteria.